Macrophage inhibitory cytokine-1 in gestational tissues and maternal serum in normal and pre-eclamptic pregnancy

Placenta

Volumn 24, Issue 1, 2003, Pages 100-106

  Marjono, A B ^a   Brown, D A ^b   Horton, K E ^a   Wallace, Euan M ^a   Breit, S N ^b   Manuelpillai, U ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MACROPHAGE INHIBITORY CYTOKINE 1; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ADHERENT CELL; AMNION CELL; ARTICLE; CESAREAN SECTION; CHILDBIRTH; CHORION; CLINICAL OBSERVATION; CONTROLLED STUDY; DECIDUA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS MEMBRANE; GESTATION PERIOD; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOTHER FETUS RELATIONSHIP; PATHOPHYSIOLOGY; PLACENTA; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; STAINING; STATISTICAL SIGNIFICANCE; SYNCYTIOTROPHOBLAST; TROPHOBLAST;

EID: 0141480794     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1053/plac.2002.0881     Document Type: Article

References (35)

1. Bootcov MR, Bauskin AR, Valenzuela SM, Moore AG, Bansal M, He XY, Zhang HP, Donnellan M, Mahler S, Pryor K, Walsh BJ, Nicholson RC, Fairlie WD, Por SB, Robbins JM & Breit SN (1997) MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-β superfamily. Proc Nat Acad Sci USA, 94, 11514-11519.
2. Brown DA, Bauskin AR, Fairlie WD, Smith MD, Liu T, Xu N & Breit SN (2002a) Antibody-based approach to high-volume genotyping for MIC-1 polymorphism. BioTechniques, 33, 118-120.
3. Brown DA, Breit SN, Buring J, Fairlie WD, Bauskin AR, Liu T, & Ridker PM (2002b) Plasma concentration of macrophage inhibitory cytokine-1 (MIC-1) and the risk of cardiovascular events in women: a nested case-control study. Lancet, 359, 2159-2163.
4. Brown MA, Hague WM, Higgins J, Lowe S, McCowan L, Oats J, Peek MJ, Rowan JA & Walters BNJ (2000) Consensus statement: The detection, investigation and management of hypertension in pregnancy: executive summary. Aust N Z J Obstet Gynaecol, 40, 133-138.
5. Caniggia I, Lye SJ & Cross JC (1997) Activin is a local regulator of human cytotrophoblast cell differentiation. Endocrinology, 138, 3976-3986.
6. Caniggia I, Grisaru-Gravnosky S, Kuliszewsky M, Post M & Lye SJ (1999) Inhibition of TGF-β3 restores the invasive capability of extravillous trophoblasts in preeclamptic pregnancies. J Clin Invest, 103, 1641-1650.
7. Challis JRG, Matthews SG, Gibb W & Lye SJ (2000) Endocrine and paracrine regulation of birth at term and preterm. Endocr Rev, 21, 514-550.
8. Chan EC, Smith R, Lewin T, Brinsmead MW, Zhang HP, Cubis J, Thornton K & Hurt D (1993) Plasma corticotropin-releasing hormone, beta-endorphin and cortisol inter-relationships during human pregnancy. Acta Endocrinol, 128, 339-344.
9. Fairlie WD, Moore AG, Bauskin AR, Russel PK, Zhang HP & Breit SN (1999) MIC-1 is a novel TGF-β superfamily associated with macrophage activation. J Leukoc Biol, 65, 2-5.
10. Florio P, Lombardo M, Gallo R, Di Carlo C, Sutton S, Genazzani AR & Petraglia F (1996) Activin A, corticotropin-releasing factor and prostaglandin F2 alpha increase immunoreactive oxytocin release from cultured human placental cells. Placenta, 17, 307-311.
11. Fowler PA, Evans LW, Groome NP, Templeton A & Knight PG (1998) A longitudinal study of maternal serum inhibin-A, inhibin-B, activin-A, activin-AB, pro-alphaC and follistatin during pregnancy. Hum Reprod, 13, 3530-3536.
12. Hamai Y, Fujii T, Yamashita T, Nishina H, Kozuma S, Mikami Y & Taketani Y (1997) Evidence for an elevation in serum interleukin-2 and tumor necrosis factor-alpha levels before the clinical manifestations of preeclampsia. Am J Reprod Immunol, 38, 89-93.
13. Kacemi A, Vervelle C, Uzan S & Challier JC (1999) Immunostaining of vascular, perivascular cells and stromal components in human placental villi. Cell Molec Biol, 45, 101-113.
14. Keelan JA, Zhou RL & Mitchell MD (2000a) Activin A exerts both pro- and anti-inflammatory effects on human term gestational tissues. Placenta, 21, 38-43.
15. Keelan JA, Zhou RL, Evans LW, Groome NP & Mitchell MD (2000b) Regulation of activin A, inhibin A, and follistatin production in human amnion and choriodecidual explants by inflammatory mediators. J Soc Gynecol Invest, 7, 291-296.
16. Lawton LN, Bonaldo MF, Jelenc PC, Qiu L, Baumes SA, Marcelino RA, de Jesus GM, Wellington S, Knowles JA, Warburton D, Brown S & Soares MB (1997) Identification of a novel member of the TGF-beta superfamily highly expressed in human placenta. Gene, 23, 17-26.
17. Lyall F, Simpson H, Bulmer JN, Barber A & Robson SC (2001) Transforming growth factor-β expression in human placenta and placental bed in third trimester normal pregnancy, preeclampsia and fetal growth restriction. Am J Pathol, 159, 1827-1838.
18. Manuelpillai U, Schneider-Kolsky M, Dole A & Wallace EM (2001) Activin-A and activin receptors in gestational tissue from preeclamptic pregnancies. J Endocrinol, 171, 57-64.
19. Marx L, Arck P, Kapp M, Kieslich C & Dietl J (1999) Leukocyte populations, hormone receptors and apoptosis in eutopic and ectopic first trimester human pregnancies. Hum Reprod, 14, 1111-1117.
20. Mirlesse V, Frankenne F, Alsat E, Poncelet M, Hennen G & Evain-Brion D (1993) Placental growth hormone levels in normal pregnancy and in pregnancies with intrauterine growth retardation. Pediatr Res, 34, 439-442.
21. Moore AG, Brown DA, Fairlie WD, Bauskin AR, Brown PK, Munier ML, Russell PK, Salamonsen LA, Wallace EM & Breit SN (2000) The transforming growth factor-β superfamily cytokine macrophage inhibitory cytokine-1 is present in high concentratons in the serum of pregnant women. J Clinical Endocrinol Metab, 85, 4781-4788.
22. Muttukrishna S, North RA, Morris J, Schellenberg JC, Taylor RS, Asselin J, Ledger W, Groome N & Redman CWG (2000) Serum inhibin-A and activin-A are elevated prior to the onset of pre-eclampsia. Hum Reprod, 15, 1640-1645.
23. Omu AE, Al-Qattan F, Diejomaoh ME & Al-Yatama M (1999) Differential levels of T helper cytokines in pre-eclampsia: pregnancy, labor and puerperium. Acta Obstet Gynecol Scand, 78, 675-680.
24. Paralkar VM, Vail AL, Grasser WA, Brown TA, Xu H, Vukicevic S, Ke HZ, Qi H, Owen TA & Thompson DD (1998) Cloning and characterization of a novel member of the transforming growth factor-β/bone morphogenetic protein family. J Biol Chem, 273, 13760-13767.
25. Petraglia F, Anceschi MM, Calza L, Garuti GC, Fusaro P, Giardino L, Genazzani AR & Vale W (1993) Inhibin and activin in human fetal membranes: evidence for a local effect on prostaglandin release. J Clin Endocrinol Metab, 77, 542-548.
26. Reister F, Frank HG, Kingdom JC, Heyl W, Kaufmann P, Rath W & Huppertz B (2001) Macrophage-induced apoptosis limits endovascular trophoblast invasion in the uterine wall of preeclamptic women. Lab Invest, 81, 1143-1152.
27. Rinehart BK, Terrone DA, Lagoo-Deenadayalan S, Barber WH, Hale EA, Martin JN Jr & Bennett WA (1999) Expression of the placental cytokines tumor necrosis factor alpha, interleukin 1beta, and interleukin 10 is increased in preeclampsia. Am J Obstet Gynecol, 181, 915-920.
28. Salamonsen LA (1999) Role of proteases in implantation. Rev Reprod, 4, 11-22.
29. Schneider-Kolsky M, D'Antona D, Evans LW, O'Connor A, Groome NP, de Kretser D, Wallace EM (2000) Maternal serum total activin A and follistatin in pregnancy and parturition. Brit J Obstet Gynaecol, 107, 995-1000.
30. Schneider-Kolsky ME, Manuelpillai U, Waldron K, Dole A & Wallace EM (2002) The distribution of activin and activin receptors in gestational tissues across human pregnancy and during labour. Placenta, 23, 294-302.
31. Strelau J, Sullivan A, Bottner M, Lingor P, Falkenstein E, Suter-Crazzolara C, Galter D, Jaszai J, Krieglstein K & Unsicker K (2000) Growth/differentiation factor-15/macrophage inhibitory cytokine-1 is a novel trophic factor for midbrain dopaminergic neurons in vivo. J Neurosci, 20, 8597-8603.
32. Wang Y & Walsh SW (1996) TNF alpha concentrations and mRNA expression are increased in preeclamptic placentas. J Reprod Immunol, 32, 157-169.
33. Wegmann TG, Lin H, Guilbert L & Mosmann TR (1993) Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a Th2 phenomenon? Immunol Today, 15, 353.
34. Weiss G (2000) Endocrinology of parturition. J Clin Endocrinol Metab, 85, 4421-4425.
35. Williams MA, Farrand A, Mittendorf R, Sorensen TK, Zingheim RW, O'Reilly GC, King IB, Zebelman AM & Luthy DA (1999) Maternal second trimester serum tumor necrosis factor-alpha-soluble receptor p55 (sTNFp55) and subsequent risk of preeclampsia. Am J Epidemiol, 149, 323-329.